Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
In Vivo (Athens, Greece)|April 11, 2000
Growth inhibitors in the treatment of malignant neoplasmsH E Kaiser, M Krenn, B Bodey, et al.
In Vivo (Athens, Greece)|April 11, 2000
Involution and neoplasms of the thymusH E Kaiser, M Krenn, B Bodey, et al.
In Vivo (Athens, Greece)|January 14, 1998
Involution of the mammalian thymus, one of the leading regulators of agingB Bodey, B Bodey, S E Siegel, et al.
In Vivo (Athens, Greece)|December 10, 1999
Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?B Bodey, B Bodey, S E Siegel, et al.
Anticancer Research|August 23, 2000
Failure of cancer vaccines: the significant limitations of this approach to immunotherapyB Bodey, B Bodey, S E Siegel, et al.
Anticancer Research|August 6, 2000
The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesisB Bodey, B Bodey, S E Siegel, et al.
In Vivo (Athens, Greece)|February 24, 2001
Prognostic significance of matrix metalloproteinase expression in colorectal carcinomasB Bodey, B Bodey, S E Siegel, et al.
Anticancer Research|August 15, 1998
Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanomaB Bodey, B Bodey, S E Siegel, et al.
Current Pharmaceutical Design|January 19, 2000
Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agentsB Bodey, B Bodey, S E Siegel, et al.
International Journal of Immunopharmacology|February 26, 2000
Review of thymic hormones in cancer diagnosis and treatmentB Bodey, B Bodey, S E Siegel, et al.
Pageof 8